stockrow
Friday 6 November 2026
Export SHPH’s income statement to Excel — free account
Shuttle Pharmaceuticals Holdings, Inc.
SHPH Healthcare Drug Manufacturers Specialty & Generic
- EPS
- +90.6%
- Free cash flow
- +82.0%
Quarter to June 2026, against a year earlier
5.31
0.27
+5.36%
Follow SHPH
Alert me
Shuttle Pharmaceuticals Holdings, Inc. (SHPH) P/E ratio
Shuttle Pharmaceuticals Holdings, Inc. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 0.0× (November 2026) — the current reading is the highest in ten years.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|
Against its own ten years
Low 0.0×
High 0.0×
Ten-year median
0.0×
Current reading's percentile
100
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| AYTU Aytu BioPharma, Inc. compare | n/m |
| RMTI Rockwell Medical, Inc. compare | n/m |
| SCYX SCYNEXIS, Inc. compare | n/m |
| TXMD TherapeuticsMD, Inc. compare | n/m |
| SHPH Shuttle Pharmaceuticals Holdings, Inc. | n/m |
| IXHL Incannex Healthcare Inc. compare | n/m |
| CPHI China Pharma Holdings, Inc. compare | n/m |
| INCR InterCure Ltd. compare | 6.2× |
| ZYBT Zhengye Biotechnology Holding Limited compare | — |
| Drug Manufacturers Specialty & Generic industry median | 20.5× |
| Healthcare sector median | 25.2× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)